Serbia signs contract to produce Russian Sputnik V vaccine

Serbia's Belgrade-based Torlak Institute for virology and vaccines signed a contract on Monday on transfer of technology with the Russian Fund for Direct Investments and the Generium pharmaceutical company to start the production of the Sputnik V vaccine in Serbia, government minister Nenad Popovic, said. Pročitaj više